Cancer, MS drugs production lines launched in Alborz province
TEHRAN (Basirat) : A pharmaceutical company with production lines for cancer and Multiple Sclerosis (MS) medications was inaugurated in Alborz province, west of Tehran, on Monday.
The company was set up by Actover, an integrated pharmaceutical company with
more than 100 products and over 1,000 employees operating in fields of
importation, marketing, production and distribution, according to IRNA.
It is planned for 100 million euros of investment to launch nine production
lines in the newly set-up company which will be partially inaugurated by the
year-end (March 20, 2019).
Actover CEO Shahrzad Naraqi explained that with launching the new pharmaceutical
company some 2,700 new jobs are created.
While last year (March 2017-March 2018) Actover produced 1.8 billion capsules
and pills by launching the new production lines it is projected that next year
7.5 billion capsules and pills will be produced, Naraqi added.
She went on to say that in the current conditions, including the brutal
sanctions hampering importation of medicines and raw materials to the country,
domestic production of such medications is a top priority.
Medicines produced in this company will be also exported to other countries in
the region, she highlighted.
Kianoush Jahanpour, spokesman for Food and Drug Administration, for his part
said that 67 percent of pharmaceutical raw materials and 97 percent of medicines
are domestically produced in Iran.
Source:TehranTimes